ArticleTranslational lung cancer research2018
Sleep better on combination therapy: SLFN11 predicts response to veliparib and temozolomide in recurrent small cell lung cancer.
Chen Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.